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  Abstract 
    Objectives  . To assess the effects of intraoperative left atrial epicardial cryoablation on rhythm and atrial and ventricular 
function.   Design  . Thirty ﬁ  ve patients with coronary artery disease and documented atrial ﬁ  brillation underwent coronary 
artery bypass surgery and concomitant cryoablation. An age and gender matched control group of 35 patients with atrial 
ﬁ  brillation underwent bypass surgery alone. Echocardiography was performed 9      32 days before and 22      6 months after 
surgery.   Results  . The proportion of patients in sinus rhythm at follow-up was 63% and 34% (p      0.04) in the cryoablation 
and control groups, respectively  .   In patients with sinus rhythm both before surgery and at follow-up, the left atrial area 
increased (p      0.002) and the mitral annular excursion during atrial contraction decreased (p      0.01) after cryoablation. 
The mitral ﬂ  ow velocity during atrial systole decreased after cryoablation (p      0.002). The LV diameter increased (p      0.03) 
and the left ventricular ejection fraction (LVEF) decreased (p      0.03) in cryoablated but not in control patients. Continued 
deterioration was seen in patients with atrial ﬁ  brillation both pre- and postoperatively.   Conclusions.   At long-term follow-up, 
a signiﬁ  cantly higher proportion of patients was in sinus rhythm in the cryoablation than in the control group. The atrial 
and ventricular function had decreased at follow-up two years after surgery. This decrease was small and occurred within 
or close to the reference values in patients with sinus rhythm at follow-up, while patients remaining in atrial ﬁ  brillation 
showed a signiﬁ  cant continued deterioration. Some subgroups were small, and the ﬁ  ndings, although statistically signiﬁ  cant, 
should be interpreted with caution.   
    Key words:     atrial ﬁ  brillation    ,    echocardiography    ,    intraoperative ablation     
  Persistent atrial ﬁ  brillation (AF) causes ﬁ  rst electrical 
and then structural remodeling of the myocardium (1). 
Reversal may occur when the ventricular rate is 
decreased and regularized during permanent pace-
maker treatment following transvenous atrioventricular 
junction ablation (2). After curative treatment using 
radiofrequency catheter ablation, an improvement in left 
ventricular ejection fraction (LVEF) was seen in patients 
in whom the decreased LVEF was believed to be due 
to AF   per se   and not primarily to comorbidities (3). 
  Intraoperative ablation of atrial ﬁ  brillation  has 
yielded promising results regarding restoration and 
maintenance of sinus rhythm (SR) (4,5). Considering 
that such patients already have advanced underlying 
structural heart disease as the indication for surgery, 
the effects on rhythm and other outcomes would not 
necessarily be the same as in patients primarily 
treated for AF. Nevertheless, we reported a 62% free-
dom of symptomatic AF recurrence 32      11 months 
after radiofrequency current ablation (RFCA) dur-
ing coronary artery bypass grafting (CABG) and an 
improvement of health-related quality of life in 
patients with long-lasting SR (6). 
  The aim of the present study was to assess the 
effects on rhythm and atrial and ventricular function 
after intraoperative left atrial cryoablation.   
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  Material and methods   
  Patients 
  Patients on the waiting list for CABG and with doc-
umented paroxysmal or persistent/permanent AF 
were eligible for participation in the study. Important 
exclusion criteria were signiﬁ  cant valvular heart dis-
ease, hypertrophic cardiomyopathy, permanent pace-
maker treatment and previous cardiac surgery. For 
each patient included, another was matched for age 
and gender and included as a control patient and 
underwent CABG but not ablation. First all cryoab-
lation      CABG patients were included on a consec-
utive basis, thereafter consecutive control patients 
matched in an age and gender based manner pair-
wise on an individual basis. No patient refused to 
participate, but some were not included because 
there was no match against a cryoablation patient or 
because matching patients had already been found 
and included. All patients were recruited between 
April 2002 and November 2004. The study was per-
formed in accordance with the Helsinki Declaration 
of 1975. Written informed consent was obtained 
from each patient and the study protocol was 
approved by the Ethics Committee of Sahlgrenska 
University Hospital (Dnr S 096-02).     
  Pre- and postoperative echocardiographic assessment 
  An echocardiographic examination (7) including tests 
of the atrial and ventricular function was performed 
before and two years after surgery. The maximal areas 
of the atria were measured by planimetry in the apical 
four-chamber view, excluding pulmonary veins and 
the left atrial appendage. The left atrial (LA) function 
was assessed during SR by M-mode recording of 
mitral ring motion (8,9). The mitral annular excur-
sion during atrial contraction was measured as 
the maximum mitral motion during the LA systole 
(Figure 1). The maximal LA ascending excursions 
were recorded at the septal, lateral, posterior and 
anterior portion of the mitral annulus, reﬂ  ecting 
the regional longitudinal maximal axis contraction 
excursions, and a mean value was obtained from the 
four sites. The measurement of the total AV plane 
displacement has a high reproducibility (10,11). 
  In addition, the mitral ﬂ  ow velocity during atrial 
systole was recorded by the pulsed Doppler tech-
nique from the apical four-chamber view, with the 
sample volume located at the tip of the mitral leaf-
lets (12). Left ventricular ejection fraction was eval-
uated visually in four-chamber and, when available, 
two-chamber views (8,13) independently by two 
experienced echocardiographists (BH and a techni-
cian), blinded to the identity of the patient. A con-
sensus was reached in case of disagreement. LVEF 
was also calculated using Simpson’    s rule in 25 
patients. The correlation between the calculated 
and the visual assessed LVEF was very good 
(R2      0.75). All echocardiographic data were aver-
aged over at least ﬁ  ve consecutive beats during AF 
and three beats during SR. All Doppler data were 
averaged over at least ﬁ  ve consecutive beats regard-
less of rhythm. All echocardiographic recordings 
were performed by an experienced echocardiogra-
phist (BH) and then stored and analyzed separately 
by two operators. All of them were blinded to the 
treatment groups. All analyses were supervised and 
overread by BH.     
  Cryoablation 
  All operations were performed by the same thoracic 
surgeons (EB, HS). The cryosurgical probe (Surgi-
frost 60 mm, ATS CryoMaze Ablation System, ATS 
Medical Inc., Minneapolis, USA) had a variable 
freezing segment (4  –  60 mm long) and an integrated 
thermocouple for temperature monitoring, capable 
of reaching a temperature of –160  °  C using an argon-
based cooling system. Cryoablation lesions were 
applied in an overlapping fashion over a period of 90 
s epicardially at each site during cardiopulmonary 
bypass on the beating and vacuum-emptied heart 
before aortic cross-clamp and cardioplegic arrest. 
The lesion set (6) consisted of circles around the 
right- and left-sided pulmonary veins with a con-
necting line between the circles. Additional lines 
were placed from the superior part of the left circle 
to the top of the left atrial appendage (LAA) and 
from the inferior part of the left circle over the AV 
groove fat pad, covering the coronary sinus and cor-
responding to the P2-P3 section of the mitral valve 
annulus on the inside. The LAA was closed from the 
    Figure 1.         M-mode registration of mitral annulus motion. Atrial 
contraction (A) is marked. During atrial systole, the left atrial 
maximal longitudinal axis excursion was measured as the 
maximum mitral motion during the left atrial contraction.      Intraoperative left atrial cryoablation     329
outside with a purse string suture in the cryoablated 
patients.     
  Postoperative management and follow-up 
  Patients were monitored by telemetry until hospital 
discharge and received warfarin according to the 
ACC/AHA/ESC guidelines at the time when the study 
was performed (14). In the case of recurrent AF, at 
least one DC cardioversion was attempted. A 12-lead 
electrocardiogram (ECG) was obtained at three, six 
and 12 months and at long-term follow-up, and the 
patients  ’   current medication, arrhythmic events, DC 
cardioversions and hospital admissions were reviewed. 
The long-term follow-up visit included a transthoracic 
echocardiography. Ablated patients were given amio-
darone or sotalol for at least three months and control 
patients received amiodarone or sotalol as needed.     
  Statistical analysis 
  No statistical calculation was done before the start 
of study. Based on previous experience with intra-
operative RF ablation we assumed that 30 evalu-
able patients per group would allow for detection 
of important differences in the restoration and 
maintenance of sinus rhythm between the groups. 
Data are presented as mean      S.D. or percentages 
unless otherwise stated. Fisher  ’  s exact test was used 
for dichotomous variables for comparisons between 
groups and the Mann-Whitney U-test was used for 
continuous/ordered variables. Wilcoxon  ’  s signed 
rank test was used for paired comparisons of 
changes between time points. A two-step strategy 
was applied to identify predictors of SR at long-
term follow-up. Nineteen baseline factors were ﬁ  rst 
tested univariately for their association with success 
at long-term follow-up. These factors were age, sex, 
body mass index, smoking habits, previous hyper-
tension, diabetes, stroke/transient ischemic attack 
(TIA), myocardial infarction, hyperlipidemia and 
chronic obstructive pulmonary disease, type and 
duration of AF, rhythm before surgery, treatment 
with angiotensin-converting enzyme (ACE) inhibi-
tors, lipid lowering drugs and antiarrhythmic agents 
at index hospital discharge, left and right atrial area 
and LVEF. Of these 19 factors, those with a uni-
variate p      0.30 were tested in a second step for 
inclusion in a logistic regression model (forward 
stepwise selection, p        0.30 for entering and 
p       0.05 for staying in the model). The log-rank 
test was used to test for differences between the 
cryoablation group and the control group regarding 
freedom from documented AF/atrial ﬂ  utter during 
follow-up, from three months after the operation 
and onwards. The corresponding Kaplan-Meier 
curves were calculated. All p-values are two-tailed 
and considered signiﬁ  cant if below 0.05.       
  Results 
  Pre- and peroperative patient characteristics are 
shown in Table I. The additional extracorporeal cir-
culation time was 21        5 minutes in cryoablated 
patients. Transthoracic echocardiography was per-
formed 9        32 days prior to and 22       6  months 
after surgery. At discharge, all patients (except one 
in the control group) were on antithrombotic treat-
ment: warfarin (n        45), heparin (n       30),  low 
molecular weight heparin (n        2) or aspirin 
(n      28). The postoperative rhythm treatment con-
sisted of amiodarone (n      33 vs. 1), sotalol (n      9 
vs. 6), betablockers (n        11 vs. 24) and calcium-
channel blockers (n      1 vs. 3) in the ablated and 
the control patients, respectively. Rhythm medica-
tion at follow-up differed little from that before sur-
gery, i.e. amiodarone two versus one, sotalol three 
versus four, digoxin four versus ﬁ  ve and betablock-
ers 22 versus 25 patients in the cryoablation and 
control groups, respectively.   
  Rhythm follow-up 
  The cumulative freedom from AF or atrial ﬂ  utter was 
signiﬁ  cantly higher in ablated than in control patients, 
p      0.0001 (Figure 2). The proportion of patients in 
SR in the ablation group versus the control group 
at three months was 91% vs. 34% (p      0.0001) and 
at long-term follow-up 63% vs. 34% (p      0.04)  .   SR 
at three months was predictive of that at long-term 
follow-up (sensitivity 95%, positive predictive value 
67%). The multivariate analysis identiﬁ  ed SR at the 
time of surgery and the LA area as predictors of long-
term SR.     
  Morbidity and mortality during follow-up 
  A pacemaker was implanted in one patient in the 
ablation group because of sick sinus syndrome  .   One 
patient with CHADS  2   score 2 developed a TIA after 
a successful DC cardioversion even though he was 
on warfarin, and another patient with CHADS  2   
score 0 with SR at follow-up and on aspirin had a 
stroke with transient visual loss. In the control 
group, two patients received an ICD six and 13 
months postoperatively, respectively, because of 
recurrent, rapid, monomorphic ventricular tachy-
cardia. Another two patients with CHADS  2   scores 
of 1 and 3, the ﬁ  rst patient in AF and the second 
in SR, developed embolic stroke with right-sided 330   B. Johansson et al.   
    Table I. Patient characteristics.   
  Cryoablation      CABG (n      35)    CABG alone (n      35)     p# 
  Age  ; years 71.7      5.3 (54  –  81) 70.1      6.8 (53  –  84) 0.36
  Sex  ; male/female (n) 32/3 32/3 1.00
  Body mass index  27.2      3.3 (22.7  –  36.5) 28.3      3.2 (20.7  –  38.0) 0.04
  Sinus/AF   (n) 17/18 11/24 0.22
  Type of AF 
Paroxysmal/persistent 20 (57) 21 (60) 1.00
AF history; months (0/1)  *  114      112 (11  –  353) 59      76 (4  –  264) 0.04
Permanent 15 (43) 14 (40) 1.00
AF history; months (0/3) 103      53 (17  –  208) 139      91 (16  –  299) 0.36
  Other comorbitidy 
Hypertension 21 (60) 23 (66) 0.80
Diabetes mellitus 10 (29) 11 (31) 1.00
History of embolic stroke/TIA 8 (23) 1 (3) 0.03
Myocardial infarction 24 (69) 16 (46) 0.09
Hyperlipidemia 26 (74) 26 (74) 1.00
Chronic obstructive pulmonary disease 2 (6) 1 (3) 1.00
Heart failure 4 (11) 3 (9) 1.00
PCI-procedures 4 (11) 7 (20) 0.51
  Symptomatology 
NYHA functional class (2/0) 0.50  *    * 
I 13 (39) 18 (51)
II 14 (42) 10 (29)
IIIA 4 (12) 5 (14)
IIIB 2 (6) 2 (6)
LVEF; % (4/3) 54.1      11.0 (25  –  70) 52.8      7.8 (38  –  70) 0.28
Left atrial area; cm  ²   (4/3) 25.4      5.8 (17  –  38) 28.0      6.4 (18  –  48) 0.10
Right atrial area; cm  ²   (4/3) 20.5      5.5 (11  –  37) 23.1      5.9 (14  –  45) 0.08
  Medication 
Betablocker 25 (71) 29 (83) 0.39
Calcium channel blocker 0 (0) 2 (6) 0.49
Digoxin 9 (26) 6 (17) 0.56
Sotalol 5 (14) 1 (3) 0.20
Amiodarone 2 (6) 0 (0) 0.49
ACE-inhibitors/ARB 16 (46) 20 (57) 0.47
Lipid lowering drugs 21 (60) 23 (66) 0.80
Diuretics 12 (34) 15 (43) 0.62
Warfarin/LMWH 20 (57) 19 (54) 1.00
Aspirin/Clopidogrel 24 (69) 20 (57) 0.46
      ACE, angiotensin converting enzyme; AF, atrial ﬁ  brillation; ARB, angiotensin receptor blocker; CABG, coronary artery bypass grafting; 
DC, direct current; LMWH, low molecular weight heparin; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; 
PCI, percutaneous coronary intervention; TIA, transient ischemic attack.     
   All results are presented as n (%) or mean      sd (min-max), unless otherwise stated, n      number.     
        *  Number of patients with missing information in the two treatment groups, respectively.     
    *    *  Ordered degree of functional class used in p-values calculation.    
  #For difference between treatment groups. 
paralysis at three months and one month after sur-
gery, respectively. Both were on aspirin because of 
contraindications for warfarin. Six patients died of 
reasons unrelated to surgery, ablation or AF.     
  Echocardiographic data in the cryoablation 
and control groups irrespective of rhythm 
  Comparison between cryoablation and control groups 
pre- and postoperatively showed a slightly larger RA 
area (p        0.04) in the control patients at follow-up 
(Table II). Regardless of the rhythm at surgery, the 
LVEF decreased, and the area of both atria increased 
in both cryo-ablated and control patients, with no sta-
tistical difference in the changes between the groups.     
  Echocardiographic data in patients with sinus rhythm 
at surgery and at follow-up 
  Twelve ablation and nine control patients were in SR 
before surgery and at long-term follow-up, all with a 
history of paroxysmal AF (Table III). At baseline, the 
left and right atrial areas were normal and highly sig-
niﬁ  cantly smaller than patients with AF on both occa-
sions. In addition to signiﬁ  cant increases in the left 
and right atrial areas, the mitral annular excursion    Intraoperative left atrial cryoablation     331
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Figure 2.         Kaplan-Meier curve showing the freedom from documented atrial ﬁ  brillation after the three month therapy stabilization period.   
during atrial contraction decreased signiﬁ  cantly  in 
cryoablated patients (23% decrease in mean value, 
p      0.01). The mitral ﬂ  ow velocity during atrial sys-
tole, measured as the A wave on pulsed Doppler 
recordings, also decreased in the ablation group (33%, 
p      0.002). The ablated patients demonstrated a sig-
niﬁ  cant increase in the mean value of the LV diameter 
(10%, p      0.03) as well, and a decrease in LVEF (6%, 
p      0.03). The only signiﬁ  cant change in the control 
group was an increase in the right atrial area.     
  Echocardiographic data in patients with atrial 
ﬁ  brillation at surgery and at follow-up 
  Nine cryoablation and 17 control patients were in 
AF both before surgery and at follow-up (Table IV), 
23 of whom had a history of persistent/permanent 
AF. In both groups the left and right atrial areas were 
highly signiﬁ  cantly increased at baseline compared 
to patients with SR on both occasions. The mean 
value of the left atrial area increased signiﬁ  cantly in 
both cryoablated and control patients (10%, 
p      0.047, and 8%, p      0.03, respectively), while the 
right atrial area increased in the control patients only 
(13%, p      0.0006). The mean LVEF value decreased 
signiﬁ  cantly in the control patients (16%, p      0.002) 
but not in the cryoablated group. There were no sta-
tistically signiﬁ   cant differences in the changes 
between the cryoablation and control patients.       
  Discussion 
  Signiﬁ   cantly more patients, who had undergone 
CABG and cryoablation were in SR at long-term 
follow-up as compared to those after CABG alone. 
Left and right atrial and left ventricular function 
deteriorated after versus before surgery regardless of 
whether the patients had been cryoablated. Cryoab-
lated patients in SR both before surgery and at long-
term follow-up had normal left and right atrial areas 
at baseline and showed an increase at follow-up with 
a decreased left atrial function expressed as a low 
mitral ﬂ  ow velocity during atrial systole and a low 
mitral annular excursion during atrial contraction. 
Most changes were small and occurred within or 
close to the normal ranges of the variables. While the 
changes in LVEF in patients in SR before and after 
intervention may not be signiﬁ  cant, considering the 
precision of the method used, the change in control 
patients with AF before and after intervention were 
large enough to represent a true deterioration. 
Patients with AF at surgery and at long-term follow-
up had enlarged left and right atrial areas preopera-
tively, and there was further enlargement in the 
control patients. 
  All patients had signiﬁ  cant chronic ischemic heart 
disease and many had had previous myocardial 
infarctions. One possible explanation for the 
decreased cardiac function in spite of that revascu-
larization was performed in all patients, might be that 
the structural remodeling caused by long-term expo-
sure to AF led to a decrease in ventricular function 
that made patients more vulnerable to continued 
deterioration in case of continued AF, as well as less 
prone to recovery in those restoring and maintaining 
SR. This hypothesis is somewhat supported by that 
cryoablated patients in AF at both operation and 
follow-up had lower LVEF, larger LV diameter and 332   B. Johansson et al.   
    Table III. Patients with sinus rhythm both before surgery and at follow-up 22      6 months postoperatively (only patients with echo both 
before surgery and at follow-up included).   
Cryo patients (n      12) Control patients (n      9)
Before surgery At follow-up p# Before surgery At follow-up p# p##
Age (years) 72      6 70      8
AF paroxysmal/permanent/persistent; n 12/0/0 9/0/0
AF duration (years) 9      87       9
median (min-max) 6 (1  –  24) 3 (     1  –  22)
Heart rate (bpm) (1/0)  *  60      8 63      10 0.43 65      13 59      9 0.07 0.04
LV diameter (mm) (1/1)  *  45      5 49      5 0.03 51      7 50      5 0.78 0.04
LVEF (%) (2/0)  *  59      6 56      8 0.03 55      9 53      8 0.50 0.61
Left atrial area (cm  ²  ) 21      4 26      5 0.002 24      4 26      5 0.06 0.28
Right atrial area (cm  ²  ) 18      4 21      4 0.01 19      3 23      4 0.02 0.99
Mitral ﬂ  ow velocity during
  atrial systole (m/s) (1/0)  *  0.76      0.14 0.51      0.20 0.002 0.70      0.21 0.64      0.26 0.27 0.009
Mitral annular excursion during
  atrial contraction (cm) (2/0)  *  0.60      0.18 0.46      0.15 0.01 0.50      0.14 0.49      0.18 0.65 0.11
  All results are presented as mean      S.D., unless otherwise stated, n, number; bpm, beats per minute. 
            *  Number of patients where information was missing in the cryo and control groups, respectively.     
    #For change within group; ##for difference in change between cryo and control groups.   
    Table II. Patients before surgery and at follow-up 22      6 months postoperatively (all echocardiographic data included in the results, only 
patients with echo at corresponding time points included).   
Patients before surgery Patients at follow-up
Cryo Controls p Cryo Controls p
Males/Females; n 30/3 29/3 1.00 25/3 28/3 1.00
Age (years) 72      5 70      7 0.38 71      5 70      7 0.57
AF paroxysmal/permanent/persistent#; n 18/15/0 15/13/4 0.14 16/12/0 16/11/4 0.19
AF duration# (years) (0/4/0/3)  *  10      88       8 0.12 9      87       8 0.13
median (min-max) 6 (1  –  29) 3 (     1  –  25) 6 (1  –  29) 3 (     1  –  25)
Sinus/AF or AFL 15/18 11/21 0.45 18/10 11/20 0.04
Heart rate (bpm) (1/0/0/1)  *  70      13 71      15 0.81 71      16 67      15 0.33
LV diameter (mm) (6/3/0/1)  *  48      5 51      6 0.06 50      6 51      7 0.48
LVEF (%) (2/0/3/1)  *  54      11 53      8 0.28 50      10 46      11 0.12
Left atrial area (cm  ²  ) (2/0/0/0)  *  25      6 28      6 0.10 29      7 30      6 0.35
Right atrial area (cm  ²  ) (2/0/2/1)  *  21      5 23      6 0.08 24      6 26      6 0.04
  All results are presented as mean      S.D., unless otherwise stated, n, number; bpm, beats per minute. 
        *  Number of patients where information was missing in the four groups, respectively.         
    #at baseline.   
larger left and right atria at baseline than those in 
whom SR was restored and maintained. 
  The surgical procedure was the same with the 
exception of the ablation and the exclusion of the left 
atrial appendage. Any difference between patients in 
SR and AF on both occasions would most likely be 
real and provide additional proof of the vicious circle 
of continuing AF as a promotor of deterioration of 
atrial function and dimensions (15). Assessment of 
atrial dimensions and function has implications in 
predicting long-term SR and the risk of AF recur-
rence. Signiﬁ  cant reverse remodeling of left atrial, 
and diastolic and systolic left ventricular diameters 
was seen in association with a 65% freedom from AF 
recurrences 30 months after endocardial RF ablation 
in patients with persistent/permanent AF undergoing 
mitral valve surgery (MVS) (4). In a study by Reyes 
et al. (16) intraoperative cryoablation of chronic AF 
in combination with mitral valve surgery resulted in 
SR in 82% of the patients at six months. Sinus 
rhythm was associated with hemodynamically effec-
tive contractions on Doppler recordings of the trans-
mitral ﬂ  ow in 70% and of the transtricuspidal ﬂ  ow 
in 100%. Similar echocardiographic results at 10 
year follow-up were reported by Sueda et al. (17) in 
patients with chronic AF undergoing mitral valve 
surgery and a simple left atrial procedure. The exact 
mechanism to explain why 30  –  40% of their patients    Intraoperative left atrial cryoablation     333
    Table IV. Patients with atrial ﬁ  brillation/ﬂ  utter both before surgery and at follow-up 22      6 months postoperatively (only patients with 
echo both before surgery and at follow-up included).   
Cryo patients (n      9) Control patients (n      17)
Before surgery At follow-up p# Before surgery At follow-up p# p##
Age (years) 70      7 70      6
AF paroxysmal/permanent/persistent; n 0/9/0 3/11/3
AF duration (years) (0/3)  *  8      59       8
median (min-max) 8 (1  –  17) 6 (     1  –  25)
Heart rate (bpm) 76      8 83      18 0.34 72      13 74      16 0.81 0.45
LV diameter (mm) (1/2)  *  51      4 49      6 0.19 51      6 51      6 0.81 0.28
LVEF (%) 47      15 45      11 0.47 53      8 44      9 0.002 0.21
Left atrial area (cm  ²  ) (1/0)  *  30      7 33      8 0.047 30      7 33      5 0.03 0.94
Right atrial area (cm  ²  ) (2/0)  *  24      4 28      7 0.09 26      6 29      6 0.0006 0.96
      All results are presented as mean      S.D., unless otherwise stated, n, number; bpm, beats per minute.     
    *  number of patients where information was missing in the cryo and control groups, respectively.     
    #for change within group; ##for difference in change between cryo and control groups.   
did not have effective left atrial contractions was 
unclear. In contrast none of the patients in SR in the 
present study showed lack of atrial function. 
  Our observations are not completely new, and 
other groups have described compromised atrial 
function after intraoperative ablation. Yuda et al. (18) 
described a reduced left atrial (LA) ﬁ  lling fraction 12 
months after MVS combined with modiﬁ  ed maze 
surgery for chronic atrial ﬁ  brillation as well as after 
modiﬁ  ed maze surgery alone. The authors proposed 
that the incisions of the LA wall and excision of the 
LA appendage in combination with non-physiologi-
cal coupling of atrioventricular contractions caused 
by delayed LA activation contributed to the decreased 
LA contractility (19). After Cox maze III surgery for 
paroxysmal AF, L ö  nnerholm et al. (20) demonstrated 
a decrease in the maximal left and right atrial areas 
after six months with a return to preoperative values 
at 56 months, but the left and right atrial contractil-
ity was signiﬁ   cantly reduced after both six and 
56 months versus baseline. The initial reduction in 
the atrial areas was proposed to depend on atrial 
scarring due to extensive surgery, while the later 
deterioration of atrial dimensions and function in 
patients with SR was unexpected. 
  Consistent with our approach, Tops et al. (21) 
compared patients in SR before and 14 months after 
percutaneous catheter ablation of AF and found sig-
niﬁ  cant improvement in the LV longitudinal strain 
and strain rate without a change in the LVEF, while 
signiﬁ  cant deterioration was seen in patients remain-
ing in AF. This also gives some support to the ﬁ  nd-
ings in our study, that patients in SR at surgery and 
follow-up, although they did not show distinct 
improvement, showed no or less deterioration than 
patients in AF at both time-points. 
  In another study by Boyd et al, patients with chronic 
AF had signiﬁ  cant persistent left atrial dysfunction, 
despite restoration and maintenance of SR, six 
months after intraoperative linear radiofrequency 
ablation (22). Global and regional atrial dysfunction 
was present in ablated patients as compared to 
patients undergoing DC cardioversion only. In the 
present study, we allowed both patients with parox-
ysmal and persistent/permanent AF to participate. 
However, consistent with the ﬁ  ndings of Boyd et al 
(22), we found a signiﬁ  cant difference in the decrease 
of the mitral ﬂ   ow velocity during atrial systole 
between the cryoablated patients and control patients 
who were in SR at surgery and at follow-up, implying 
that the ablation procedure itself was at least in part 
responsible for some deterioration, found as late as 
22 months after surgery. The exclusion of the atrial 
appendage in ablated patients might possibly have 
contributed. 
  The duration and possibly the type of AF, whether 
or not symptomatic, is no doubt of importance and, 
if long, considerable structural remodeling may have 
taken place to make reversal less probable. In addi-
tion, patients undergoing concomitant intraoperative 
ablation have considerable structural heart disease, 
constituting a sicker subpopulation that is likely to 
be more difﬁ  cult to treat than patients with primary 
electrical disease. In our study, a history of myocar-
dial infarction in 69% of the cryoablated and 46% 
of the control patients may have added to the risk 
of a deterioration of the postoperative ventricular 
function and dimensions. 
  When applied endocardially, cryoablation carried 
a minimal risk of thrombus formation and preserved 
underlying tissue architecture, probably because of 
its preservation of collagen tissue. There seemed to 
be a low risk of adjacent tissue injury, e.g. the cir-
cumﬂ   ex coronary artery and the esophagus, com-
pared to RF energy (23). In an animal study with 
epicardial cryo clamp lesions on the beating heart, 334   B. Johansson et al.   
Milla et al. (24) demonstrated conduction block in 
pulmonary veins and the left atrial appendage even 
though full transmurality was not achieved. In the 
same study, linear epicardial cryoablation using a 
10-cm linear cryo probe demonstrated transmurality 
in 84% of the applications. In our study, cryoablation 
was performed epicardially on a vacuum   “  emptied  ”   
beating heart, on-pump, to minimize the re-warming 
effect of intracardiac blood ﬂ  ow.   
  Limitations 
  We used a case-control study design and cannot exclude 
that a randomized study would have generated slightly 
different results. However, this would most probably 
have needed a multicenter trial design, and standard-
ized echocardiographic measurements would then have 
been more difﬁ  cult to achieve. The numbers of patients 
in the subgroups are small, and the results, although 
statistically signiﬁ   cant, thus should be regarded as 
hypothesis generating rather than deﬁ  nite answers.       
  Conclusions 
  Patients undergoing CABG with or without con-
comitant left atrial epicardial cryoablation showed a 
pattern of decreased atrial and ventricular function 
at long-term follow-up. Differences were found 
between patients who were in SR or AF both at 
operation and follow-up, respectively, but the sub-
groups were small and the results should be interpreted 
with caution and need to be conﬁ   rmed in a larger 
patient population. SR before surgery and the left atrial 
area at baseline were independently predictive of SR 
at long-term follow-up.                
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